Determination of cefepime and cefpirome in human serum by high-performance liquid chromatography using an ultrafiltration for antibiotics serum extraction

被引:36
作者
Breilh, D [1 ]
Lavallee, C
Fratta, A
Ducint, D
Cony-Makhoul, P
Saux, MC
机构
[1] Victor Segalen Univ, Clin Pharmacokinet Dept, Bordeaux, France
[2] Haut Leveque Hosp, Oncohematol Dept, F-33604 Pessac, France
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 1999年 / 734卷 / 01期
关键词
cefepime; cepirome;
D O I
10.1016/S0378-4347(99)00343-6
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to describe a high-performance liquid chromatography (HPLC) assay for the determination of cefepime and cefpirome in human serum without changing chromatographic conditions. The assay consisted to measure cefepime and cefpirome which were unbound to proteins having a molecular mass of 10 000 or more by ultrafiltration followed by HPLC with a Supelcosil ABZ+ column and UV detection at a wavelength of 263 nm. The assay was been found to be Linear and has been validated over the concentration range 200 to 0.50 mu g/ml for both cefepime and cefpirome, from 200 mu l serum, extracted. In future, the assay will support therapeutic drug monitoring for cefepime and cefpirome in neutropenic patients in correlation with microbiological parameters such as MIC90 (minimal inhibitory concentration of antibiotic which kills 90% of the initial bacterial inoculum) and clinical efficacy. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:121 / 127
页数:7
相关论文
共 14 条
[1]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ANALYSIS OF BMY-28142 IN PLASMA AND URINE [J].
BARBHAIYA, RH ;
FORGUE, ST ;
SHYU, WC ;
PAPP, EA ;
PITTMAN, KA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (01) :55-59
[2]   CEFEPIME MONOTHERAPY FOR THE EMPIRICAL-TREATMENT OF FEVER IN GRANULOCYTOPENIC CANCER-PATIENTS [J].
EGGIMANN, P ;
GLAUSER, MP ;
AOUN, M ;
MEUNIER, F ;
CALANDRA, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :151-163
[3]   High-performance liquid chromatographic assay for cefepime in serum [J].
Elkhaili, H ;
Linger, L ;
Monteil, H ;
Jehl, F .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1997, 690 (1-2) :181-188
[4]   IS THERE A ROLE FOR MONOTHERAPY WITH BETA-LACTAM ANTIBIOTICS IN THE INITIAL EMPIRICAL MANAGEMENT OF FEBRILE NEUTROPENIC CANCER-PATIENTS [J].
HATHORN, JW ;
PIZZO, PA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 :41-54
[5]  
HUBER L, 1998, LC GC INT FEB, P96
[6]   MICROANALYTICAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR CEFPIROME IN HUMAN-MILK AND URINE [J].
KEARNS, GL ;
JOHNSON, VA ;
HENDRY, IR ;
WELLS, TG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 574 (02) :356-360
[7]   COMPARISON OF A NEW CEPHALOSPORIN, BMY 28142, WITH OTHER BROAD-SPECTRUM BETA-LACTAM ANTIBIOTICS [J].
KESSLER, RE ;
BIES, M ;
BUCK, RE ;
CHISHOLM, DR ;
PURSIANO, TA ;
TSAI, YH ;
MISIEK, M ;
PRICE, KE ;
LEITNER, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (02) :207-216
[8]   EFFECT OF PROTEIN-BINDING ON SERUM BACTERICIDAL ACTIVITIES OF CEFTAZIDIME AND CEFOPERAZONE IN HEALTHY-VOLUNTEERS [J].
LAM, YWF ;
DUROUX, MH ;
GAMBERTOGLIO, JG ;
BARRIERE, SL ;
GUGLIELMO, BJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :298-302
[9]   PULSE DOSING VERSUS CONTINUOUS INFUSION OF ANTIBIOTICS - PHARMACOKINETIC-PHARMACODYNAMIC CONSIDERATIONS [J].
LEBEL, M ;
SPINO, M .
CLINICAL PHARMACOKINETICS, 1988, 14 (02) :71-95
[10]   USE OF CEPHALOSPORINS IN THE IMMUNOLOGICALLY COMPROMISED PATIENT [J].
NEWLAND, AC ;
GAYA, H .
DRUGS, 1987, 34 :205-215